{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T01:27:13Z","timestamp":1794274033241,"version":"4.9.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T00:00:00Z","timestamp":1682380800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T00:00:00Z","timestamp":1682380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Clin Microbiol Antimicrob"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Finegoldia magna<\/jats:italic>\n                      (formerly known as\n                      <jats:italic>Peptococcus magnus<\/jats:italic>\n                      or\n                      <jats:italic>Peptostreptococcus magnus<\/jats:italic>\n                      ) belonging to phylum Firmicutes, class Clostridia and genus Finegoldia, is the only species known to cause infections in human beings. Amongst Gram positive anaerobic cocci,\n                      <jats:italic>F. magna<\/jats:italic>\n                      is known to be the most virulent with a high pathogenic potential. Significant upsurge in antimicrobial resistance among anaerobes has been documented by various studies.\n                      <jats:italic>F. magna<\/jats:italic>\n                      is known to be susceptible to most of the anti-anaerobic antimicrobials, however, multidrug resistant strains are being reported in literature. The present study was undertaken to highlight the role of\n                      <jats:italic>F. magna<\/jats:italic>\n                      in clinical infections and to analyze their antimicrobial susceptibility patterns.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The present study was conducted in a tertiary care teaching hospital in Southern India. 42 clinical isolates of\n                      <jats:italic>F. magna<\/jats:italic>\n                      recovered from diverse clinical infections between January 2011 to December 2015 were studied. These isolates were subjected to antimicrobial susceptibility testing against metronidazole, clindamycin, cefoxitin, penicillin, chloramphenicol and linezolid.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among the 42 isolates studied, majority of them were revived from diabetic foot infections (31%) followed by necrotizing fasciitis (19%) and deep-seated abscesses (19%). All the\n                      <jats:italic>F. magna<\/jats:italic>\n                      isolates showed good in-vitro activity against metronidazole, cefoxitin, linezolid and chloramphenicol. Clindamycin and penicillin resistance were observed against 9.5% and 2.4% of the isolates respectively. However, \u03b2-lactamase activity was not detected.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The antimicrobial resistance among anaerobes varies from pathogen to pathogen and region to region. Hence, a deep understanding of resistance pattern is necessary for better management of clinical infections.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12941-023-00583-1","type":"journal-article","created":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T06:03:30Z","timestamp":1682402610000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Understanding antimicrobial susceptibility profile of Finegoldia magna: an insight to an untrodden path"],"prefix":"10.1186","volume":"22","author":[{"given":"Seema","family":"Shetty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renuka","family":"Anegundi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6781-5579","authenticated-orcid":false,"given":"Padmaja Ananth","family":"Shenoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shashidhar","family":"Vishwanath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,25]]},"reference":[{"key":"583_CR1","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1111\/1574-6976.12005","volume":"37","author":"EC Murphy","year":"2013","unstructured":"Murphy EC, Frick IM. Gram-positive anaerobic cocci\u2013commensals and opportunistic pathogens. FEMS Microbiol Rev. 2013;37:520\u201353.","journal-title":"FEMS Microbiol Rev"},{"key":"583_CR2","unstructured":"Veloo ACM. Gram-positive anaerobic cocci: identification and clinical relevance.Groningen: s.n., 2011;144p."},{"key":"583_CR3","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1128\/CMR.11.1.81","volume":"11","author":"DA Murdoch","year":"1998","unstructured":"Murdoch DA. Gram-positive anaerobic cocci. Clin Microbiol Rev. 1998;11:81\u2013120.","journal-title":"Clin Microbiol Rev"},{"key":"583_CR4","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1086\/605672","volume":"49","author":"PY Levy","year":"2009","unstructured":"Levy PY, Fenollar F, Stein A, Borrione F, Raoult D. Finegoldia magna: a forgotten pathogen in prosthetic joint infection rediscovered by molecular biology. Clin Infect Dis. 2009;49:1244\u20137.","journal-title":"Clin Infect Dis"},{"key":"583_CR5","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.3390\/microorganisms9081665","volume":"9","author":"F Gu\u00e9rin","year":"2021","unstructured":"Gu\u00e9rin F, Dejoies L, Degand N, Guet-Revillet H, Janvier F, Corvec S, et al. On Behalf of the Gmc Study Group. In Vitro Antimicrobial susceptibility profiles of Gram-Positive anaerobic Cocci responsible for human invasive infections. Microorganisms. 2021;9:1665.","journal-title":"Microorganisms"},{"key":"583_CR6","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.ijantimicag.2007.11.006","volume":"31","author":"J Brazier","year":"2008","unstructured":"Brazier J, Chmelar D, Dubreuil L, Feierl G, Hedberg M, Kalenic S, et al. ESCMID Study Group on Antimicrobial Resistance in anaerobic Bacteria. European surveillance study on antimicrobial susceptibility of Gram-positive anaerobic cocci. Int J Antimicrob Agents. 2008;31:316\u201320.","journal-title":"Int J Antimicrob Agents"},{"key":"583_CR7","doi-asserted-by":"publisher","first-page":"648134","DOI":"10.1155\/2015\/648134","volume":"2015","author":"II Shilnikova","year":"2015","unstructured":"Shilnikova II, Dmitrieva NV. Evaluation of Antibiotic susceptibility of Gram-Positive anaerobic Cocci isolated from Cancer patients of the N. N. Blokhin Russian Cancer Research Center. J Pathog. 2015;2015:648134.","journal-title":"J Pathog"},{"key":"583_CR8","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3390\/antibiotics6040025","volume":"6","author":"M Gajd\u00e1cs","year":"2017","unstructured":"Gajd\u00e1cs M, Spengler G, Urb\u00e1n E. Identification and Antimicrobial susceptibility testing of anaerobic Bacteria: Rubik\u2019s cube of clinical Microbiology? Antibiot (Basel). 2017;6:25.","journal-title":"Antibiot (Basel)"},{"key":"583_CR9","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1128\/CMR.00086-12","volume":"26","author":"I Brook","year":"2013","unstructured":"Brook I, Wexler HM, Goldstein EJ. Antianaerobic antimicrobials: spectrum and susceptibility testing. Clin Microbiol Rev. 2013;26:526\u201346.","journal-title":"Clin Microbiol Rev"},{"key":"583_CR10","volume-title":"Wadsworth\u2013KTL anaerobic bacteriology Manual","author":"HR Jousimies\u2013Somer","year":"2002","unstructured":"Jousimies\u2013Somer HR, Summanen P, Citron DM, Baron EJ, Wexler HM, Finegold SM. Wadsworth\u2013KTL anaerobic bacteriology Manual. 6th ed. California: Star Publishing Company; 2002.","edition":"6"},{"key":"583_CR11","volume-title":"Methods for Antimicrobial susceptibility testing of anaerobic Bacteria: approved Standard. CLSI document M11\u2013A6","author":"Clinical and Laboratory Standards Institute","year":"2013","unstructured":"Clinical and Laboratory Standards Institute. Methods for Antimicrobial susceptibility testing of anaerobic Bacteria: approved Standard. CLSI document M11\u2013A6. 6th ed. Wayne, Pennsylvania, USA: Clinical and Laboratory Standards Institute; 2013.","edition":"6"},{"key":"583_CR12","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/j.1574-695X.2012.00962.x","volume":"65","author":"G Donelli","year":"2012","unstructured":"Donelli G, Vuotto C, Cardines R, Mastrantonio P. Biofilm-growing intestinal anaerobic bacteria. FEMS Immunol Med Microbiol. 2012;65:318\u201325.","journal-title":"FEMS Immunol Med Microbiol"},{"key":"583_CR13","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1093\/jac\/dkg316","volume":"52","author":"JS Brazier","year":"2003","unstructured":"Brazier JS, Hall V, Morris TE, Gal M, Duerden BI. Antibiotic susceptibilities of Gram-positive anaerobic cocci: results of a sentinel study in England and Wales. J Antimicrob Chemother. 2003;52:224\u20138.","journal-title":"J Antimicrob Chemother"},{"key":"583_CR14","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/j.cmi.2018.02.008","volume":"24","author":"E Nagy","year":"2018","unstructured":"Nagy E, Boyanova L, Justesen US, ESCMID Study Group of Anaerobic Infections. How to isolate, identify and determine antimicrobial susceptibility of anaerobic bacteria in routine laboratories. Clin Microbiol Infect. 2018;24:1139\u201348.","journal-title":"Clin Microbiol Infect"},{"key":"583_CR15","doi-asserted-by":"publisher","first-page":"102111","DOI":"10.1016\/j.anaerobe.2019.102111","volume":"61","author":"ACM Veloo","year":"2020","unstructured":"Veloo ACM, Tokman HB, Jean-Pierre H, Dumont Y, Jeverica S, Lienhard R, et al. ESGAI study group. Antimicrobial susceptibility profiles of anaerobic bacteria, isolated from human clinical specimens, within different european and surrounding countries. A joint ESGAI study. Anaerobe. 2020;61:102111.","journal-title":"Anaerobe"},{"key":"583_CR16","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1128\/AAC.37.8.1649","volume":"37","author":"GA Pankuch","year":"1993","unstructured":"Pankuch GA, Jacobs MR, Appelbaum PC. Susceptibilities of 428 gram-positive and -negative anaerobic bacteria to Bay y3118 compared with their susceptibilities to ciprofloxacin, clindamycin, metronidazole, piperacillin, piperacillin-tazobactam, and cefoxitin. Antimicrob Agents Chemother. 1993;37:1649\u201354.","journal-title":"Antimicrob Agents Chemother"},{"key":"583_CR17","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1128\/AAC.01771-09","volume":"55","author":"AC Veloo","year":"2011","unstructured":"Veloo AC, Welling GW, Degener JE. Antimicrobial susceptibility of clinically relevant gram-positive anaerobic cocci collected over a three-year period in the Netherlands. Antimicrob Agents Chemother. 2011;55:1199\u2013203.","journal-title":"Antimicrob Agents Chemother"},{"key":"583_CR18","doi-asserted-by":"publisher","first-page":"479","DOI":"10.3343\/alm.2015.35.5.479","volume":"35","author":"Y Lee","year":"2015","unstructured":"Lee Y, Park YJ, Kim MN, Uh Y, Kim MS, Lee K. Multicenter study of antimicrobial susceptibility of anaerobic bacteria in Korea in 2012. Ann Lab Med. 2015;35:479\u201386.","journal-title":"Ann Lab Med"},{"key":"583_CR19","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3343\/alm.2019.39.2.190","volume":"39","author":"JH Byun","year":"2019","unstructured":"Byun JH, Kim M, Lee Y, Lee K, Chong Y. Antimicrobial susceptibility patterns of anaerobic bacterial clinical isolates from 2014 to 2016, including recently named or renamed species. Ann Lab Med. 2019;39:190\u20139.","journal-title":"Ann Lab Med"},{"key":"583_CR20","doi-asserted-by":"publisher","first-page":"3993","DOI":"10.1128\/AAC.00481-10","volume":"54","author":"Y Lee","year":"2010","unstructured":"Lee Y, Park Y, Kim MS, Yong D, Jeong SH, Lee K, et al. Antimicrobial susceptibility patterns for recent clinical isolates of anaerobic bacteria in South Korea. Antimicrob Agents Chemother. 2010;54:3993\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"583_CR21","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.anaerobe.2017.09.003","volume":"48","author":"T Yunoki","year":"2017","unstructured":"Yunoki T, Matsumura Y, Yamamoto M, Tanaka M, Hamano K, Nakano S, et al. Kyoto-Shiga Clinical Microbiology Study Group. Genetic identification and antimicrobial susceptibility of clinically isolated anaerobic bacteria: a prospective multicenter surveillance study in Japan. Anaerobe. 2017;48:215\u201323.","journal-title":"Anaerobe"},{"key":"583_CR22","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.anaerobe.2017.04.007","volume":"47","author":"S Jeverica","year":"2017","unstructured":"Jeverica S, Kolenc U, Mueller-Premru M, Papst L. Evaluation of the routine antimicrobial susceptibility testing results of clinically significant anaerobic bacteria in a slovenian tertiary-care hospital in 2015. Anaerobe. 2017;47:64\u20139.","journal-title":"Anaerobe"},{"key":"583_CR23","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1093\/cid\/ciu395","volume":"59","author":"AN Schuetz","year":"2014","unstructured":"Schuetz AN. Antimicrobial resistance and susceptibility testing of anaerobic bacteria. Clin Infect Dis. 2014;59:698\u2013705.","journal-title":"Clin Infect Dis"},{"key":"583_CR24","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/S0924-8579(03)00087-6","volume":"22","author":"J Behra-Miellet","year":"2003","unstructured":"Behra-Miellet J, Calvet L, Dubreuil L. Activity of linezolid against anaerobic bacteria. Int J Antimicrob Agents. 2003;22:28\u201334.","journal-title":"Int J Antimicrob Agents"}],"container-title":["Annals of Clinical Microbiology and Antimicrobials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-023-00583-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12941-023-00583-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-023-00583-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T06:04:45Z","timestamp":1682402685000},"score":1,"resource":{"primary":{"URL":"https:\/\/ann-clinmicrob.biomedcentral.com\/articles\/10.1186\/s12941-023-00583-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,25]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["583"],"URL":"https:\/\/doi.org\/10.1186\/s12941-023-00583-1","relation":{},"ISSN":["1476-0711"],"issn-type":[{"value":"1476-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,25]]},"assertion":[{"value":"25 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and this study was approved by the Institutional Ethical Committee of Kasturba Medical College & Kasturba Hospital, Manipal (IEC1:41\/2022 dated 09-02-2022). This study was solely laboratory based and hence, the need for informed consent was waived off by the institutional ethical committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30"}}